Zobrazeno 1 - 10
of 204
pro vyhledávání: '"C Dosquet"'
Autor:
J.-M. Miclea, Patrice Viens, J. Geneve, S. Provent, Catherine Lhommé, F. Viret, Joseph Gligorov, G. Lefevre, Jean-Pierre Lotz, B. Gosse, Vincent Ribrag, C. Cailliot, A. Goetschel, François Lokiec, Frédéric Selle, C. Dosquet, Michel Fabbro, Patricia Pautier
Publikováno v:
Bone Marrow Transplantation. 37:669-675
Topotecan has demonstrated activity in ovarian carcinomas. In order to increase the tumour response rate and to define the maximum tolerated dose (MTD) of topotecan, we decided to develop a high-dose phase I regimen supported by stem cell support. Hi
Autor:
J. Soudon, C. Lucas, M.-H. Brillanceau, Ahmad Awada, M. G. Poullain, P. Eftekhary, Dominique de Valeriola, S. Giacchetti, Fabien Calvo, B. Giroux, Martine Piccart, Béatrice Gerard, Michel Marty, C. Dosquet, Harry Bleiberg
Publikováno v:
Annals of Oncology. 13:1925-1934
S 16020, a new 9-OH olivacine derivative, is a novel topoisomerase II inhibitor with activity in cell lines presenting the classical multidrug resistance phenotype. This report summarizes, in addition to pharmacokinetic data, the whole phase I clinic
Autor:
C. Dosquet, J.-L. Wautier
Publikováno v:
Clinical Hemorheology and Microcirculation. 12:817-829
Publikováno v:
Annals of the rheumatic diseases. 67(6)
Behcet disease (BD) is a chronic systemic auto-inflammatory immune disorder with generalised vasculitis of the arteries and veins. It was originally described as orogenital aphthous ulcerations and uveitis but the disease can affect any organ or syst
Publikováno v:
Infection and Immunity. 65:2434-2436
Growth of Chlamydia trachomatis serotypes L2 and L3 in a human monocytic cell line, U-937, increased the rate of interleukin 8 (IL-8) release 100-fold. Heat-killed chlamydiae induced a 10-fold-lower level of production of IL-8. IL-8 may play an impor
Autor:
Eliane Gluckman, Isabelle Fournier, Anne M. Dickinson, Dominique Charron, M Rae, Antoine Toubert, Xiao N. Wang, E A Douglas, C Dosquet
Publikováno v:
Bone marrow transplantation. 35(6)
EBV transformation of cells from cord blood donations: relevance to future retrospective studies on cord blood transplants
Autor:
J. López, M. Jiménez, J. Peláez, M. A. Arce, M. J. Asensio, F. Arnalich, A. Hernanz, J. Zweigner, H. -J. Gramm, N. Lamping, A. Kopf, A. Asmus, R. R. Schumann, J. Zimmermann, H. Meinhold, W. Beier, K. Wegscheider, M. Murphy, A. Catania, M. Cutuli, L. Garofalo, F. Valenza, J. M. Lipton, D. Berger, E. Boelke, N. Hiki, R. Lissner, A. Arnold, F. Hausmann, M. Seidelmann, H. G. Beger, H. D. Braunmueller, E. Bōlke, U. Schmidt, S. Ott, H. Seidelmann, C. Bohuon, J. Raymond, M. Assicot, F. Moulin, M. Bergeret, P. Lebon, D. Gendrei, M. Lantéri-Minet, J. Y. Scoazec, C. Dosquet, P. Beyne, H. Voitot, J. M. Mencia-Huerta, P. Lettéron, D. Lebrec, C. H. Lehmann, K. Egerer, A. Georgiew, M. Weber, W. J. Kox, F. M. Brunkhorst, Z. F. Forycki, J. Wagner, S. E. Orfanos, A. Armaganidis, H. Bardouniotou, I. Mavrommati, J. D. Catravas, J. Economidou, Ch. Roussos
Publikováno v:
Intensive Care Medicine. 22:S336-S338
Autor:
Thierry Letourneau, Isabelle Six, Brigitte Jude, Christine C Dosquet, Christophe Bauters, Frédéric Mouquet, Régis Bordet, Bernard Dupuis, Eric Van Belle, Delphine Corseaux, Michel E. Bertrand, Benoit Vallet
Publikováno v:
Growth factors (Chur, Switzerland). 22(3)
The role of basic fibroblast growth factor (bFGF) in atherosclerotic plaque formation is incompletely understood. Although it may act as a proatherogenic factor due to its stimulatory effect on smooth muscle cell growth, previous studies have suggest
Publikováno v:
Pediatric dermatology. 18(4)
We report a case of generalized infantile myofibromatosis with favorable outcome despite systemic involvement. Elevated urinary bFGF levels during the active phase of the disease suggested an angiogenic stimulation in the pathogenesis of myofibromato
Publikováno v:
European journal of haematology. 66(4)
We tested the immunosuppressive effect of cord blood (CB) natural killer (NK) cells using highly purified CB NK cells in mixed lymphocyte cultures (MLC) containing autologous CB T cells as responders. Control cultures were done without NK cells. Our